Professor Sarah Parish
BSc, MSc, DPhil
Professor of Medical Statistics and Epidemiology
- MRC Programme Leader
Sarah Parish studied Mathematics at Bristol and Oxford Universities and joined the unit which became CTSU (and is now part of NDPH) in 1978. She has played a major role as a statistician in the establishment, conduct and interpretation of CTSU’s series of ground-breaking large-scale randomised trials in the treatment and prevention of cardiovascular disease. She has also been active in developing large-scale blood-based observational studies with extensive biomarker panels and genotyping. As the Director of Statistics in Vascular Trials and Genetic Epidemiology, she now leads statistical teams engaged in a spectrum of complimentary research. Her particular interests include: identifying genetic risk factors for the side-effects of common cardiovascular treatments; investigating causality in relation to factors such as adiposity and dementia that are responsible for major burdens of disease, using the large UK and China Kadoorie biobanks.
A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions.
Chan MS. et al, (2021), J Gerontol A Biol Sci Med Sci
Height and risk of ischaemic stroke subtypes: a Mendelian randomisation study
Linden A. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2415 - 2415
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Rocca B. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2926 - 2926
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342
Effects of Omega-3 Fatty Acid Supplements on Arrhythmias.
Parish S. et al, (2020), Circulation, 141, 331 - 333